Decorative Graphic
Important Notice
This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada. Inari Medical is currently developing separate websites for our products tailored to these other global and regional markets.
Decorative Graphic
Venous
Thromboembolism
+ Women's Health
VTE IN WOMEN:
A HEALTH RISK
While everyone is at risk of developing VTE, pregnancy is tied to an increased risk of developing a blood clot.Women are especially at risk for blood clots during pregnancy, childbirth, and up to three months after delivery.
Risks for developing
dangerous blood clots
increase during pregnancy
and up to 3 months
postpartum.1
PEs account for ~10% of
pregnancy-related deaths
in the US.2
Combined oral
contraceptives increase
the risk of VTE by 3x.3
Compared to women who are not pregnant,pregnant women are:
5x
20x
more likely to
have a blood clot
during pregnancy2
more likely to have a blood
clot in the 3 months
after giving birth2
WHY DO PREGNANT WOMEN HAVE A HIGHER RISK FOR BLOOD CLOTS?
Several factors increase a pregnant woman’s risk for a blood clot.
  • The primary reason for the increased risk of VTE in pregnancy is hypercoagulability. During pregnancy, the blood clots more easily to reduce blood loss during labor and delivery.
  • A growing baby presses on the blood vessels around a woman’s pelvis, causing less blood flow to the legs. This usually occurs later in pregnancy.
  • Extended periods of inactivity or immobility can cause blood to pool and slow blood flow, such as during bed rest or while recovering from childbirth.
Learn more about the risk factors for blood clots
WHY ARE BLOOD CLOTS DANGEROUS FOR PREGNANT WOMEN?
Pulmonary embolism (PE) is the number one cause of pregnancy-related death in the United States.1Blood clots can also harm an unborn baby by restricting blood flow throughout the body.
How can I protect myself
from a blood clotduring pregnancy?
  • Become familiar with the signs and symptoms of blood clots.
  • Consider elevated risk factors for pregnant women, such as a C-section, long periods of being still, and complications during childbirth.
  • Consult with your doctor about family history of blood clots, reducing your risk, and creating a blood clot prevention plan.
AS YOU PREPARE FOR BABY, DON'T FORGET TO TAKE CARE OF YOURSELF
A woman is at increased risk for a dangerous blood clot throughout her pregnancy, during childbirth, and up to three months after her baby is born. When you take care of yourself, you take care of your developing baby too.
First Trimester
Second Trimester
Third Trimester
Up to 3 Months after delivery
Where can I learn more about pregnancy and blood clots?
Patient Stories: Sources:
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment.

Sources:

1. Fennerty, A. Venous thromboembolic disease and cancer. Postgraduate Medical Journal 2006 Oct; 82:642-648.
2. CDC: https://www.cdc.gov/ncbddd/dvt/materials/cancer-and-blood-clots.html

FlowTriever indications for use:
The FlowTriever Retrieval/Aspiration System is indicated for: (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The FlowTriever Retrieval/Aspiration System is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism.

CONTRAINDICATIONS
  • Not intended for use in the cerebral, carotid, or coronary arteries
  • Not intended for use in endarterectomy procedures or vessel dilation
  • Not indicated for the removal of fibrous, adherent, or calcified material (e.g., atherosclerotic plaque)
  • Not intended for use in vessels < 6 mm
  • Not intended for use with power injector

WARNINGS
  • Intended for single use only. Do not re-sterilize or reuse this device. Reprocessing and re-sterilizatio increase the risks of patient infection and compromised device performance.
  • Should be used in conjunction with fluoroscopic guidance and proper anticoagulation agents
  • Examine the devices before use to verify they are not damaged
  • Use before the "Use By" date specified on the product packaging
  • Excess pressure may result in catheter damage or patient injury
  • Avoid using excessive force to advance or retract against resistance. If excessive resistance occurs, retrac and collapse the distal disks into the catheter and remove the device. Excessive force against resistance may result in damage to the device or vessel perforation.
  • In the event of patient deterioration, remove FlowTriever Catheter/Triever Catheter and assess situation
  • Ensure that FlowTriever wireform disks are withdrawn into Triever Guide Catheter prior to removal fro patient to avoid vascular damage.
  • Do not use in blood vessels that have a history of therapeutic irradiation. Vessel perforation may occur

ClotTriever indications for use:
The ClotTriever Thrombectomy System consists of the ClotTriever Catheter and ClotTriever Sheath. The ClotTriever Thrombectomy System is indicated for: (1) The non-surgical removal of thrombi and emboli from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The ClotTriever Thrombectomy System is intended for use in the peripheral vasculature including deep vein thrombosis (DVT).

CONTRAINDICATIONS:
  • Not intended for use without anticoagulation.
  • Not intended for use in the cerebral, carotid or coronary vasculature.
  • Not intended for use in the pulmonary arteries.
  • Not intended for use in endarterectomy procedures or vessel dilation.
  • Not indicated for the removal of fibrous, adherent or calcified material (e.g., atherosclerotic plaque).
  • Not intended for use in vessels < 6 mm.
  • Not intended for use with power injectors.

WARNINGS
  • When used in patients with an IVC filter, damage to the filter, the collection bag, or dislodgment of the VC filter, etc. may occur.
  • When the ClotTriever device is in the path of an exposed stent, damage to the stent, the collection bag, or dislodgment of the stent, etc. may occur.
  • Intended for single use only. Do not re-sterilize or reuse this device. Reprocessing and re-sterilization increase the risks of patient infection and compromised device performance.
  • Should be used in conjunction with fluoroscopic guidance and proper anticoagulation agents.
  • Examine the ClotTriever Catheter prior to insertion to verify it is not damaged.
  • Use before the "Use By" date specified on the product packaging.
  • Avoid using excessive force to advance or retract against resistance. If excessive resistance is encountered, retract and collapse the collection bag and coring element into the Outer Catheter
    • and remove the device. Excessive force against resistance may result in damage to the device or vessel.
  • In the event of patient deterioration, remove the ClotTriever System.
  • Ensure that ClotTriever Catheter is withdrawn into the ClotTriever Sheath prior to removal from patient to avoid vascular damage